U.S. NeuroSurgical Holdings, Inc.
USNU · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1,061 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $13 | $20 | $39 | $86 |
| Gross Profit | -$13 | -$20 | -$39 | $975 |
| % Margin | – | – | – | 91.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,793 | $765 | $1,386 | $1,064 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$13 | -$20 | -$39 | $0 |
| Operating Expenses | $1,780 | $745 | $1,347 | $1,064 |
| Operating Income | -$1,793 | -$765 | -$1,386 | -$88 |
| % Margin | – | – | – | -8.3% |
| Other Income/Exp. Net | -$425 | -$51 | -$147 | -$465 |
| Pre-Tax Income | -$2,218 | -$816 | -$1,533 | -$554 |
| Tax Expense | -$163 | $0 | $39 | $420 |
| Net Income | -$2,055 | -$816 | -$1,572 | -$881 |
| % Margin | – | – | – | -83% |
| EPS | -0.13 | -0.088 | -0.17 | -0.11 |
| % Growth | -47.9% | 48.3% | -54.5% | – |
| EPS Diluted | -0.13 | -0.088 | -0.17 | -0.11 |
| Weighted Avg Shares Out | 15,377 | 9,284 | 7,842 | 7,792 |
| Weighted Avg Shares Out Dil | 15,377 | 9,285 | 7,842 | 7,792 |
| Supplemental Information | – | – | – | – |
| Interest Income | $9 | $0 | $0 | $8 |
| Interest Expense | $0 | $2 | $0 | $3 |
| Depreciation & Amortization | $13 | $765 | $39 | $35 |
| EBITDA | -$2,205 | -$49 | -$1,494 | -$515 |
| % Margin | – | – | – | -48.5% |